Abbott (ABT) Tops Q4 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
Abbott Reports Second-Quarter 2018 Results
July 18, 2018 7:45 AM EDTABBOTT PARK, Ill., July 18, 2018 /PRNewswire/ --Â Abbott (NYSE: ABT)Â today announced financial results for the second quarter ended June 30, 2018.
Second-quarter worldwide sales of $7.8 billion increased 17.0 percent on a reported basis and 8.0 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.40 in the second quarter. Adjusted diluted EPS from continuing operations, which excludes specified items, was $0.73, above Abbott's previous guidance range. Abbott is raising its full-year 2018 EPS guidance range, which continues to reflect strong double-digit growth. Abbott projects full-year... More